Science Current Events | Science News | Brightsurf.com
 

Ovarian Cancer Current Events | Ovarian Cancer News

Page 1 of 100 | 2491 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Women without regular medical care at increased risk of ovarian cancer
In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer. The high mortality is in part due to the difficulty of detecting and diagnosing this condition at an early stage.   view more (2007-03-27)

New developments in biomarkers for epithelial ovarian cancer
With the genomic revolution radical improvement has been made in methods of detection of ovarian cancer.   view more (2007-11-30)

Increased ovarian cancer risk not found in women with breast cancer family history
Women with a strong family history of breast cancer but who don't have breast cancer genetic mutations can now be reassured that they are not at increased risk for ovarian cancer.   view more (2005-09-21)

PET-CT highly accurate for detecting ovarian cancer recurrence
The accuracy of PET-CT for detecting recurrent ovarian cancer is high, more accurate even than either CT or PET alone, says a new study by researchers from Massachusetts General Hospital in Boston.   view more (2006-05-02)

Detection of glycoprotein could identify ovarian and uterine cancers with poor prognosis (p 865)
Issue 13 September 2003 Embargoed 0001 h (London time) 12 September 2003. The detection of a specific protein molecule could help oncologists identify uterine and ovarian cancers with poor prognosis and thereby enable better disease management of women with aggressive uterine or ovarian cancer,... view more (2003-09-10)

Pregnancy is possible after cancer treatment
It has been reported for the first time in Germany that healthy ovarian tissue has been taken from a non-pregnant woman with cancer and then re-implanted after cancer therapy.   view more (2008-04-24)

Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR.   view more (2008-04-18)

Study finds multiple markers for breast and ovarian cancer
Scientists from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) have made a promising discovery that could improve the early diagnosis of breast and ovarian cancers through a simple blood test.   view more (2005-08-01)

Early results indicate radiofreqency ablation useful in treating ovarian cancer metastasis
Percutaneous radiofrequency ablation, a procedure that uses a high frequency electric current to kill tumor cells, is effective in achieving local control in selected patients with metastasis from ovarian cancer.   view more (2006-09-29)

Drinking tea associated with lower risk of ovarian cancer
Women who drank at least two cups of tea a day had a lower risk of ovarian cancer than those who did not drink tea, according to a study in the December 12/26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.   view more (2005-12-13)

Low-fat diet possibly linked to lower risk of ovarian cancer
A low-fat diet may decrease the risk of ovarian cancer in postmenopausal women.   view more (2007-10-10)

Healthcare professionals need training to help them talk more comfortably about sexual issues
Ovarian cancer affects sexual functioning, but healthcare professionals' knowledge about this is inadequate, as is their communication with patients about sexual issues, concludes a study in this week's BMJ. Interviews were conducted with 15 women with ovarian cancer and 43 clinicians and nurses in... view more (2001-10-09)

U of Minnesota study finds thalidomide shows promise for treatment of recurrent ovarian cancer
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher.   view more (2008-02-28)

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.   view more (2008-01-02)

Tulane pioneers novel ovarian cancer treatment
The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in... view more (2005-07-18)

Gene therapy completely suppresses ovarian cancer growth in animal model
University of Pittsburgh School of Medicine researchers have used gene therapy to either completely abolish or significantly inhibit tumor progression in a mouse model of ovarian cancer.   view more (2006-06-05)

PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer
Combined positron emission tomography (PET) and computed tomography (CT) scanning of patients in the early stages of ovarian cancer can enable physicians to determine whether the cancer has spread to nearby lymph nodes without having to perform surgery.   view more (2008-06-17)

Combination Chemotherapy Best Option For Treating Relapsed Ovarian Cancer (p 2099)
Results of a European study in this week's issue of THE LANCET suggest that combination treatment with paclitaxel and platinum-based chemotherapy could result in a modest but important survival benefit for women with relapsing ovarian cancer compared with women treated with platinum-based... view more (2003-06-19)

Multimarker assay for ovarian cancer most promising to date
The search for a specific protein that could help diagnose ovarian cancer in its early stages has for years eluded researchers who are seeking a reliable and accurate test for the disease.   view more (2006-04-03)

Researchers working on a better method of detecting ovarian cancer
According to the National Cancer Institute, ovarian cancer causes more deaths than any other cancer of the female reproductive system. An estimated 20,180 new cases of ovarian cancer are expected in the United States this year.   view more (2006-04-04)

Swedish researchers link endometriosis with increased risk of some cancers
Madrid, Spain: Women with endometriosis have an increased risk of developing ovarian cancer, non-Hodgkin's lymphoma, endocrine and brain cancers, a Swedish researcher told the annual meeting of the European Society of Human Reproduction and Embryology today (Wednesday 2 July). However, Dr... view more (2003-06-29)

Study suggests chemotherapy diminishes fertility in breast cancer patients
Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve - the capacity of the ovaries to provide eggs capable of being fertilized - compared to women who have never had breast cancer, according to a study led by... view more (2008-05-30)

Ovarian cancer responds to aspirin derivative with chemo
A new study using ovarian cancer cell lines shows promise in treating the deadly disease by combining the chemotherapy drug cisplatin with an aspirin-like compound to make recurrent cancer cells less resistant to the chemotherapy.   view more (2006-02-16)

EMSY: a new gene for breast/ovarian cancer
A new human breast and ovarian cancer gene has just been described by investigators in the last issue of the journal Cell. The gene, called EMSY, also characterises a subset of breast cancer with poorer survival, which makes it a potentially important diagnostic tool.   view more (2003-12-10)

Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovarian cancer were presented at this week's Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers, by researchers from The University of Texas M. D. Anderson Cancer Center.   view more (2008-03-11)
Page 1 of 100 | 2491 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com